Guanze Medical Keeps Issued Shares Steady at 950 Million; Confirms Public Float Compliance in May 2026

Bulletin Express06-08

Guanze Medical Information Industry (Holding) Co., Ltd. (Guanze Medical) filed its Monthly Return for Equity Issuer for the period ended 31 May 2026, confirming that the group’s share structure remained unchanged during the month.

The authorised share capital stayed at 10.00 billion ordinary shares with a par value of HKD 0.01 each, equivalent to HKD 100.00 million in nominal terms.

Issued share capital was unchanged at 950.00 million ordinary shares, with no treasury shares outstanding. Consequently, total issued shares also remained at 950.00 million.

The company affirmed that it continued to meet the Main Board’s minimum public-float requirement of 25% of issued shares as of 31 May 2026.

No share options, warrants, convertible securities, or other equity instruments were issued, exercised, converted, or cancelled during the month, and there were no Hong Kong Depositary Receipts outstanding.

Company Secretary Cheng Cheung King submitted the return on 8 June 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment